Clinical and genetic characterization of neonatal non-ketotic hyperglycinemia: a rare case with SLC6A9 gene mutation
DOI:
https://doi.org/10.18203/2320-6012.ijrms20251653Keywords:
SLC6A9 gene, Nonketotic hyperglycinemia, CSF glycineAbstract
Nonketotic hyperglycinemia (NKH) is a rare autosomal recessive disorder caused by mutations in the glycine cleavage system (GCS), leading to glycine accumulation in cerebrospinal fluid (CSF) and plasma, with an increased CSF-to-plasma glycine ratio. Typically presenting in the neonatal period, symptoms include lethargy, poor feeding, hypotonia, seizures, and encephalopathy, often resulting in severe neurological impairment. Early diagnosis is vital but challenging due to the rarity and nonspecific nature of symptoms, especially in populations with high consanguinity rates. We report a neonate born to consanguineous parents who developed severe encephalopathy within 48 hours of birth despite normal antenatal and perinatal findings. The infant exhibited poor feeding, seizures, and worsening neurological status. NKH was confirmed by elevated CSF glycine levels and genetic analysis identifying a novel SLC6A9 mutation. This case highlights the importance of considering NKH in neonatal encephalopathy and the need for genetic testing and counseling in at-risk groups.
Metrics
References
Hennermann JB. Clinical variability in glycine encephalopathy. Future Neurol. 2006;1(5):621-30. DOI: https://doi.org/10.2217/14796708.1.5.621
Tada K, Kure S. Nonketotic hyperglycinemia: pathophysiological studies. Proc Japan Acad Ser B. 2005;81B:411. DOI: https://doi.org/10.2183/pjab.81.411
Bhumika S, Basalingappa KM, Gopenath TS, Basavaraju S. Glycine encephalopathy. Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):132. DOI: https://doi.org/10.1186/s41983-022-00567-6
Eulenberg V, Armsen W, Betz H, Gomeza J. Glycine transporters: essential regulators of neurotransmission. Trends Biochem Sci. 2005;30(6):325-33. DOI: https://doi.org/10.1016/j.tibs.2005.04.004
Alfadhel M, Nashabat M, Qahtani HA, Alfares A, Mutairi FA, Shaalan HA, et al. Mutation in SLC6A9 encoding a glycine transporter causes a novel form of of non ketotic hyperglycinemia in humans. Hum Genet 2016;135(11):1263-8. DOI: https://doi.org/10.1007/s00439-016-1719-x
Dinopoulos A, Matsubara Y, Kure S. Atypical variants of nonketotic hyperglycinemia. Molecular Genetics Metabol. 2005;86(1-2):61-9. DOI: https://doi.org/10.1016/j.ymgme.2005.07.016
Volpe JJ. Neurology of the Newborn. Vol. 1. Philadelphia: WB Saunders. Hyperammonemia and other disorders of amino acid metabolism. 2008: 659-667. DOI: https://doi.org/10.1016/B978-1-4160-3995-2.10014-7
Van Hove JLK, Coughlin C II, Swanson M, Julia BH, Margaret PA, Jerry F, et al. Nonketotic Hyperglycinemia. In: GeneReviews®. Seattle (WA): University of Washington, Seattle. 1993.
Applegarth DA, Toone JR. Nonketotic hyperglycinemia (glycine encephalopathy): Laboratory diagnosis. Mol Genet Metab. 2001;74:139-46. DOI: https://doi.org/10.1006/mgme.2001.3224
Iqbal M, Prasad M, Mordekar SR. Non ketotic hyperglycinemia case series. J Pediatr Neurosci. 2015;10(4):355-8. DOI: https://doi.org/10.4103/1817-1745.174445
Van Hove JL, Vande KK, Hennermann JB, Mahieu V, Declercq P, Mertens S, et al. Benzoate treatment and the glycine index in nonketotic hyper glycinaemia. J Inherit Metab Dis. 2005;28:651e63. DOI: https://doi.org/10.1007/s10545-005-0033-x
Downloads
Published
How to Cite
Issue
Section
